View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AEGON: merger of Corebridge and Equitable, implications for Transamerica. Flow Traders: Equity strong as crypto fades. IBA: Net debt above, FY26 REBIT guidance on the low side, 2H25 REBIT a bit below. Sofina: Final NAV 2% above preliminary results. Zabka: Peer Dino Polska FY25 results

Hilde Van Boxstael ... (+5)
  • Hilde Van Boxstael
  • Kristof Samoy
  • Livio Luyten
  • Thomas Couvreur
  • Wim Hoste
Wim Hoste
  • Wim Hoste

IBA FIRST LOOK: FY25 REBIT +58%, FY26 guidance of at least 17% growth

IBA reported solid FY25 results, with revenues up 24% to € 620m (kbcse: € 614m), driven by an accelerated backlog conversion and good order intake. However, gross profit margins still contracted by 150bps to 32.2%, driven by negative mix effects from legacy lower margin PT contracts. Nevertheless, as this was already anticipated, the FY25 REBIT of € 27.4m came in above the guidance of at least € 25m and was in line with our forecast. The 2026 guidance calls for a REBIT of at least € 32m (kbcse: ...

 PRESS RELEASE

IBA delivers strong FY 2025 results with solid execution in all segmen...

IBA delivers strong FY 2025 results with solid execution in all segments    Read the entire full-year 2025 results press release  Louvain-la-Neuve, Belgium, 27 March 2026 - IBA (Ion Beam Applications S.A.), today announces its consolidated results of 2025 financial year, with strong execution across the businesses. Robust commercial momentum, notably in Proton Therapy, resulted in a historic order intake and a new all-time high backlog. Delivered in line with guidance, the year marks continued progress in the execution of IBA’s strategic roadmap to the benefit of all its stakeholders. R...

 PRESS RELEASE

IBA réalise des résultats solides pour l'exercice 2025, avec une exécu...

IBA réalise des résultats solides pour l'exercice 2025, avec une exécution maîtrisée dans tous les segments   pour lire l'intégralité du communiqué de presse des résultats annuels 2025 Louvain-La-Neuve, Belgique, 27 mars 2026 - IBA (Ion Beam Applications S.A.), annonce aujourd’hui ses résultats consolidés pour l'exercice 2025, avec une exécution maîtrisée dans tous les segments d'activité. La forte dynamique commerciale, notamment en Proton Therapy, se traduit par une prise de commandes et un carnet de commandes record. Conforme aux objectifs annoncés, l'année a été marquée par la poursu...

 PRESS RELEASE

Arcadis nominates Carl Trowell to its supervisory board

Arcadis nominates Carl Trowell to its supervisory board                           PRESS RELEASE ARCADIS NOMINATES CARL TROWELL TO ITS SUPERVISORY BOARD Amsterdam, March 27 2026 – Arcadis (EURONEXT: ARCAD), the world’s leading company delivering data-driven sustainable design, engineering, and consultancy solutions for natural and built assets, today announces the nomination of Carl Trowell for appointment to its Supervisory Board for a four-year term.  Carl Trowell currently serves as President of Strategic Infrastructure at National Grid PLC and is a member of its Group Executive Commi...

 PRESS RELEASE

L'IBA lance myQA MatriXX AiR et fait évoluer l'assurance qualité spéci...

L'IBA lance myQA MatriXX AiR et fait évoluer l'assurance qualité spécifique des patients en thérapie par particules La première gamme de chambres d'ionisation sans fil pour la thérapie par particules, PSQA, fournissant une vérification rapide et fiable des traitements par protons et ions carbone, et adaptée aux techniques émergentes telles que la radiothérapie FLASH et ARC. Louvain-la-Neuve, Belgique, 21 mars 2026 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie d'accélérateurs de particules et fournisseur mondial de solutions de dosimétrie et d'assurance qu...

 PRESS RELEASE

IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle...

IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle Therapy The first wireless ionization chamber array for particle therapy PSQA delivers fast, reliable verification for proton and carbon ion treatments, supporting emerging techniques such as FLASH and ARC radiotherapy. Louvain-la-Neuve, Belgium, 21 March 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global provider of dosimetry and quality assurance (QA) solutions, announces the launch of myQA MatriXX AiR, a high resolution, wireless 2D ionization chamber...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

IBA: IBA to supply 4 Cyclone KIUBE cyclotrons to Telix Pharmaceuticals in US. Lotus Bakeries: Biscoff spread shortages in DACH countries. Unilever plc: Morris dancing. Zabka: Small beat in 4Q25, guidance reiterated for FY26

Hilde Van Boxstael ... (+4)
  • Hilde Van Boxstael
  • Livio Luyten
  • Wim Hoste
  • Wim Lewi
 PRESS RELEASE

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in...

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S. Louvain-la-Neuve, Belgium– March 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announced it has signed a contract with Telix Pharmaceuticals Limited (Telix; ASX: TLX, NASDAQ: TLX), a precision oncology company, for the initial order of four Cyclone® KIUBE cyclotrons at standard IBA conditions1. The systems will be installed at select RLS Radiopharmacies (RLS) sites in...

 PRESS RELEASE

Telix choisit le Cyclone® KIUBE d’IBA pour étendre ses capacités de pr...

Telix choisit le Cyclone® KIUBE d’IBA pour étendre ses capacités de production aux États‑Unis Louvain‑la‑Neuve, Belgique, le 20 mars 2026 — IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélérateurs de particules et premier fournisseur mondial de solutions de production de radiopharmaceutiques, annonce la signature d’un contrat avec Telix Pharmaceuticals Limited (Telix ; ASX : TLX, NASDAQ : TLX), entreprise d’oncologie de précision, pour une première commande de quatre cyclotrons Cyclone® KIUBE aux conditions standards d’IBA1. Les systèmes seront installés...

 PRESS RELEASE

IBA Notice of Full Year 2025 Results and Conference Call

IBA Notice of Full Year 2025 Results and Conference Call FY25 results webcast to take place on Friday, 27 March 2026 at 3pm CET Louvain-la-Neuve, Belgium, 13 March 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the full year 2025 on Friday, 27 March 2026 at 7am CET. Conference Call Information IBA’s management team will host team will host a conference call and webcast conducted in English to present the half year results, followed by a Q&A session. The conference...

 PRESS RELEASE

IBA : Publication des résultats annuels 2025 et conférence web

IBA : Publication des résultats annuels 2025 et conférence web La conférence sur les résultats de l’exercice 2025 aura lieu le vendredi 27 mars 2026 à 15h00, heure de Bruxelles Louvain-la-Neuve, Belgique, le 13 mars 2026 - IBA (Ion Beam Applications S.A le leader mondial des technologies d’accélération de particules, annonce qu’elle publiera ses résultats financiers consolidés de l’exercice 2025 le vendredi 27 mars 2026 à 7h00, heure de Bruxelles. Informations relatives à la conférence La direction du Groupe IBA présentera les résultats de l’exercice 2025 lors d’une conférence web et t...

Guy Sips ... (+8)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Thibault Leneeuw
  • Wim Hoste
  • Wim Lewi
Guy Sips ... (+10)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update March 2026: Removing Aedifica – Adding Pr...

The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continue into 2027. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. The highly anticipated AI productivity gains also will have to transpire sooner or later or a US market correction becomes unavoidable. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We...

Martijn Den Drijver
  • Martijn Den Drijver
 PRESS RELEASE

IBA – ACQUISITION OF OWN SHARES

IBA – ACQUISITION OF OWN SHARES IBA – ACQUISITION OF OWN SHARES Louvain-la-Neuve, Belgium, March 2nd, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026. Under this program, IBA has requested a financial intermediary to repurchase up to 400,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until September 30th, 2026 (included), effect...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch